Scedosporium apiospermum is a filamentous, ubiquitous environmental mold that can cause various human infections. It is an opportunistic pathogen, primarily affecting individuals with low immunity or underlying health conditions. 

1. apiospermum is found worldwide, and its prevalence varies depending on geographic location and the population studied. It is more commonly reported in regions with a warmer climate, such as tropical and subtropical areas. Recently it has been found in temperate regions.
2. apiospermum is primarily acquired through environmental exposure. It is commonly found in soil, contaminated water sources (such as stagnant or polluted water), and decaying organic matter. Inhalation of fungal spores is the most accessible entry route, particularly for respiratory infections. However, direct injection through traumatic wounds or surgical procedures can lead to localized infections.

The main risk factor for S. apiospermum infections is immunosuppression. People with compromised immune systems, such as solid organ transplant recipients, individuals with hematological malignancies, and those with AIDS, are more susceptible to these infections. Other risk factors include chronic lung diseases (e.g., cystic fibrosis), long-term corticosteroid use, and prior trauma or surgery. 

• Kingdom: Fungi  
• Phylum: Ascomycota  
• Class: Sordariomycetes  
• Order: Microascales  
• Family: Microascaceae  
• Genus: Scedosporium  
• Species: Scedosporium apiospermum

Structure: 

• Scedosporium apiospermum is a filamentous saprophytic fungus. It has a complex and multicellular structure characteristic of filamentous fungi.  
• Hyphae: S. apiospermum consists of hyphae, which are long, branching, and thread-like structures. The hyphae form the main body of the fungus and are composed of multiple cells. 
• Mycelium: The interconnected network of hyphae is known as the mycelium. The mycelium grows through the substrate, such as soil or organic matter, and functions in nutrient absorption and expansion of the fungus. 
• Conidiophores: S. apiospermum produces specialized structures called conidiophores, which bear conidia. They are typically ellipsoidal or cylindrical and have a size range of approximately 3-6 µm in width and 5-20 µm in length. 
• Conidia are the asexual spores produced by S. apiospermum. These spores are typically unicellular and responsible for the fungus’s dispersal and reproduction. Conidia are usually small, oval-shaped, and pale brown and can be found in chains or clusters at the ends of conidiophores. 
• Cleistothecia are the fruiting bodies produced during the sexual phase of S. apiospermum‘s life cycle. These structures are spherical and contain asci (sac-like structures) that produce ascospores. The size of cleistothecia can vary but is generally around 100-200 µm in diameter. 
• Apothecia: S. apiospermum is capable of sexual reproduction, although it is less common than asexual reproduction. Sexual reproductive structures, known as apothecia, can develop under specific conditions. Apothecia contain ascospores, the sexual spores of the fungus. 

• Scedosporium apiospermum does not have well-defined antigenic types or serotypes like other fungi.
• The classification into specific antigenic types has yet to be extensively studied or established for this fungus. 

The pathogenesis of Scedosporium apiospermum involves several steps that allow the fungus to establish infection and cause disease in susceptible individuals. Here’s a brief overview of the pathogenesis process: 

• Entry and colonization: S. apiospermum primarily enter the host through inhalation of fungal spores present in the environment, such as soil or contaminated water sources. The spores can also gain access through direct injection into wounds or surgical sites. Once the pathogen enters the host, it colonizes the affected tissues. 
• Adhesion and tissue invasion: S. apiospermum possesses various mechanisms to adhere to host tissues. It can produce adhesive proteins or utilize structures like hyphae and conidia to attach to host cells. The fungus then invades the surrounding tissues, penetrating the host cells and extracellular matrix. 
• Immune response: The host immune response is critical in the pathogenesis of S. apiospermum infections. The fungus triggers an immune response involving activating immune cells, like neutrophils and macrophages, and releasing inflammatory mediators. However, S. apiospermum can evade and suppress the immune response to some extent, contributing to its pathogenicity. 
• Tissue damage and disease manifestations: As S. apiospermum grows and invades host tissues, it can cause damage to the affected organs. The specific disease manifestations depend on the site of infection. Common clinical presentations include respiratory infections (pneumonia, lung abscesses), cutaneous and soft tissue infections, osteomyelitis, and invasive sinusitis. Disseminated infections can occur in individuals with severely compromised immune systems. 
• Antifungal resistance: S. apiospermum has demonstrated inherent resistance to several antifungal agents, making treatment challenging. This resistance is attributed to mechanisms such as the production of efflux pumps and alterations in the target site of antifungal drugs. Antifungal therapy often requires a multidisciplinary approach, including surgical intervention and prolonged administration of appropriate antifungal agents. 

• The innate immune system provides the primary defense against Scedosporium apiospermum. The innate immune response components, such as neutrophils, macrophages, and dendritic cells, play critical roles in recognizing and phagocytosing the fungal cells. These immune cells release antimicrobial peptides, reactive oxygen species, and pro-inflammatory cytokines to limit the growth and spread of the fungus. 
• The adaptive immune response comes into play following the recognition of S. apiospermum antigens by antigen-presenting cells, such as dendritic cells. It leads to the activation of T and B cells, mediating a targeted immune response. T cells, specifically CD4+ helper T cells, produce cytokines that further enhance the activity of phagocytes and promote the development of specific immune responses. B cells, on the other hand, produce antibodies that can recognize and neutralize the fungus. 
• Cell-mediated immunity: Cell-mediated immunity is crucial for the clearance of S. apiospermum. CD8+ cytotoxic cells and CD4+ T cells are essential in recognizing and eliminating infected host cells. CD4+ T cells release cytokines that activate phagocytes, enhance antifungal activity, and promote the development of an effective immune response. CD8+ T cells directly kill infected cells through the release of cytotoxic molecules. 
• Granulomatous response: In some cases, S. apiospermum infections can form granulomas. Granulomas are organized structures composed of immune cells, including macrophages, multinucleated giant cells, and lymphocytes. These structures help contain the fungal infection, limit its spread, and prevent systemic dissemination. 

• Scedosporiosis: It is the common infection caused by S. apiospermum, a deep fungal subcutaneous infection. 
• Pulmonary infections: S. apiospermum commonly causes respiratory tract infections. Clinical manifestations include cough, fever, chest pain, shortness of breath, and sputum production. It can lead to pneumonia, lung abscesses, or bronchopulmonary colonization in severe cases. 
• Cutaneous and subcutaneous infections: S. apiospermum can infect the skin and underlying tissues. Clinical manifestations include localized redness, swelling, pain, and the formation of abscesses or chronic non-healing ulcers. These infections often occur in individuals with wounds, burns, or compromised skin integrity. 
• Central Nervous System Infections: S. apiospermum can invade the central nervous system, resulting in brain abscesses, meningitis, and other neurological complications. These infections can cause severe neurological deficits and potentially life-threatening complications. 
• Septic Arthritis and Osteomyelitis: S. apiospermum can cause severe infections in bones and joints, leading to septic arthritis and osteomyelitis. These conditions can result in significant pain, joint destruction, and functional impairment. 
• Disseminated infections: In immunocompromised individuals, S. apiospermum can spread throughout the body, causing disseminated infections. Symptoms are contrasted depending on the organs involved but may include fever, respiratory distress, neurological abnormalities, hepatosplenomegaly, and renal dysfunction. 

• Microscopic examination of clinical specimens, like sputum, wound swabs, or tissue biopsy samples, can be performed to visualize the characteristic morphological features of S. apiospermum. The fungus appears as septate hyphae and conidia when observed under a microscope. 
• Culture: Fungal culture is the gold standard for diagnosing S. apiospermum infections. Clinical specimens are inoculated onto appropriate fungal culture media, such as Sabouraud dextrose agar or potato dextrose agar, and incubated at an optimal temperature (typically 25-30°C). S. apiospermum grows as characteristic filamentous colonies, which can be further identified based on their macroscopic and microscopic features. So, it is essential to mark that the cultural process may take several days to weeks for definitive identification. 
• Molecular methods: Molecular techniques, such as polymerase chain reaction (PCR) assays, can detect and identify S. apiospermum directly from clinical samples. PCR assays targeting specific fungal genes or regions can provide rapid and sensitive detection of the fungus, aiding in early diagnosis. 
• Serological tests: Serological tests, including enzyme-linked immunosorbent assay (ELISA), may detect specific antibodies against S. apiospermum antigens. These tests are beneficial in patients with suspected systemic or disseminated infections. 
• Imaging studies: Chest X-rays and computed tomography (CT) scans are often utilised to determine the concentration and location of S. apiospermum infections. These imaging modalities can help identify lung infiltrates, abscesses, sinus involvement, or other structural abnormalities associated with the infection. 

• Implementing standard infection control practices, such as hand hygiene, proper cleaning and disinfection of surfaces, and appropriate waste management, can help prevent the spread of S. apiospermum in healthcare settings. 
• Maintaining a clean and hygienic environment prevents S. apiospermum infections. It includes regular cleaning and disinfecting surfaces, proper ventilation, and minimizing sources of fungal contamination, such as damp or moldy environments. 
• Immunocompromised individuals, like those with HIV/AIDS, organ transplant recipients, or patients undergoing immunosuppressive therapies, are at higher risk for S. apiospermum infections. It is essential to take additional precautions for these individuals, such as avoiding exposure to contaminated environments, implementing strict hygiene practices, and considering prophylactic antifungal therapy in certain high-risk cases. 
• Healthcare workers or individuals at higher risk of exposure to S. apiospermum should use appropriate PPE, including gloves, masks, gowns, and eye protection when handling potentially contaminated materials or caring for infected patients. 
• For individuals at high risk or those diagnosed with S. apiospermum infections, appropriate antifungal therapy is essential. The choice of antifungal agents depends on factors such as the site and severity of infection, the immune status of the patient, and susceptibility testing results. Antifungal therapy should be guided by a healthcare professional experienced in managing fungal infections. 

• https://en.wikipedia.org/wiki/Scedosporium 
• https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082694